Today: 20 May 2026
Imperial Brands stock price rises as buyback rolls on — what to watch before Monday open
1 February 2026
1 min read

Imperial Brands stock price rises as buyback rolls on — what to watch before Monday open

London, February 1, 2026, 09:33 GMT — Market closed

  • On Friday, Imperial Brands ended the day 1.39% higher, closing at 3,066p (£30.66)
  • Company announced an additional buyback tranche as part of its £1.45 billion programme
  • Up next: ex-dividend date on Feb. 19; half-year results due May 12

Imperial Brands (IMB.L) ended Friday at 3,066 pence (£30.66), rising 42 pence, or 1.39%, while the FTSE 100 gained 0.51%. Roughly 1.06 million shares traded, with the stock yielding 5.23% in dividends at close.

With London closed Sunday, all eyes shift to Monday’s reopening (Feb. 2) and if the stock can maintain its gains. For Imperial, the immediate focus remains on cash returns — buybacks and dividends — rather than any new product news.

Feb. 19 is marked as the next ex-dividend date, so anyone buying after won’t be eligible for the upcoming payout. The final dividend is set for March 31, with half-year results due May 12.

Imperial disclosed in a stock exchange filing Friday that it repurchased 88,533 shares at an average price of 3,028.56 pence each, with individual trades ranging from 2,994 to 3,050 pence. This buyback is part of a £1.45 billion programme announced on Oct. 30. The company confirmed it plans to cancel these shares, leaving 791,080,747 shares outstanding, excluding treasury stock.

Share buybacks reduce the number of shares available in the market. This can boost earnings per share over time, even when profits remain steady. But daily buyback amounts tend to be modest, and the support they provide often vanishes quickly if the activity slows down.

Imperial’s shift coincided with UK tobacco stocks gaining ground late in the week. British American Tobacco closed Friday 1.13% higher, at 4,376 pence.

The sector’s risk remains familiar: regulatory changes can hit fast, and investors watch cigarette volume declines closely. If pricing fails to offset those drops, buybacks merely cushion the impact a bit.

Imperial has highlighted tobacco pricing and the rising popularity of smoking alternatives as key growth factors, alongside its strategy of returning cash to shareholders.

Monday’s open will focus on follow-through, ahead of positioning for the Feb. 19 ex-dividend date. The next major event to watch is May 12, when the half-year results are released.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Previous Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Opendoor stock slid nearly 8% into the weekend — what OPEN investors watch next
Next Story

Opendoor stock slid nearly 8% into the weekend — what OPEN investors watch next

Go toTop